NETVATION DL MEDICINE

NetVation DL Medicine is a Chengdu, China based biopharmaceutical company dedicated to advancing novel therapeutic entities into the clinic for Metabolic, Inflammatory and Cancer related diseases. NetVation DL Medicine (DL Medicine) has a strategic partnership with HitGen Ltd around accessing and integrating HitGen's DNA-encoded library (DEL) technology platform of over 150 billion compounds for use against DL Medicine targets. To best utilize HitGen's world leading DEL technology, DL Medicine i... s developing a proprietary drug discovery platform to identify novel, potent chemical lead matter with excellent drug-like properties as initial starting points for lead development. This platform will be used in screening against both standard druggable targets as well as unconventional (i.e. classical undruggable) targets. DL Medicine will also utilize the DEL platform to aid in the validation of biological pathways through specific target intervention methodologies. By accessing the emerging R&D landscape in China, which consists of strong government support and a rapidly developing market and economy, including a highly professional CRO and CMO industry, DL Medicine is positioned as a resource-efficient discovery operation utilizing the enormous capabilities of the Asia-Pacific biotechnology region.More